Jan-Hendrik Hofmeyr

Prof. Jan-Hendrik Hofmeyr


Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 July 2018 in Autophagy
Verified
Journal Article
Closed access
ATAndre du Toit
Andre du Toit
JHJan-Hendrik Hofmeyr
Jan-Hendrik Hofmeyr
TGThomas J. Gniadek
Thomas J. Gniadek
BLBen Loos
Ben Loos
Macroautophagy/autophagy is a proteolytic pathway that is involved in both bulk degradation of cytoplasmic proteins as well as in selective degradation of cytoplasmic organelles. Autophagic flux is often defined as a measure of autophagic degradation activity, and many techniques exist to assess autophagic flux. Although these techniques have generated invaluable information about the autophagic system, the quest continues for developing methods that not only enhance sensitivity and provide a means of quantification, but also accurately reflect the dynamic character of the pathway. Based on the theoretical framework of metabolic control analysis, where the autophagosome flux is the quantitative description of the rate a flow along a pathway, here we treat the autophagy system as a multi-step pathway. We describe a single-cell fluorescence live-cell imaging-based approach that allows the autophagosome flux to be accurately measured. This method characterizes autophagy in terms of its complete autophagosome and autolysosome pool size, the autophagosome flux, J, and the transition time, τ, for autophagosomes and autolysosomes at steady state. This approach provides a sensitive quantitative method to measure autophagosome flux, pool sizes and transition time in cells and tissues of clinical relevance. Abbreviations: ATG5/APG5, autophagy-related 5; GFP, green fluorescent protein; LAMP1, lysosomal-associated membrane protein 1; MAP1LC3/LC3, microtubule-associated protein 1 light chain 3; J, flux; MEF, mouse embryonic fibroblast; MTOR, mechanistic target of rapamycin kinase; nA, number of autophagosomes; nAL, number of autolysosomes; nL, number of lysosomes; p-MTOR, phosphorylated mechanistic target of rapamycin kinase; RFP, red fluorescent protein; siRNA, small interfering RNA; τ, transition time; TEM, transmission electron microscopy.

1 January 2013 in Ecology and Society
Verified
Journal Article
Open access
PCPaul Cilliers
Paul Cilliers
HBHarry C. Biggs
Harry C. Biggs
SBSonja Blignaut
Sonja Blignaut
ACAiden G. Choles
Aiden G. Choles
JHJan-Hendrik Hofmeyr
Jan-Hendrik Hofmeyr
DRDirk J. Roux
Dirk J. Roux
Cilliers, P., H. C. Biggs, S. Blignaut, A. G. Choles, J. S. Hofmeyr, G. P. W. Jewitt, and D. J. Roux. 2013. Complexity, modeling, and natural resource management. Ecology and Society 18(3): 1.http://dx.doi.org/10.5751/ES-05382-180301

6 December 2012 in The FEBS Journal
Verified
Journal Article
Closed access
PDF file
DPDaniel C. Palm
Daniel C. Palm
Johann RohwerJohann Rohwer
Johann Rohwer
JHJan-Hendrik Hofmeyr
Jan-Hendrik Hofmeyr

25 January 2011 in BMC Systems Biology
Verified
Journal Article
Open access
PDF file
CPChe Pillay
Che Pillay
JHJan-Hendrik Hofmeyr
Jan-Hendrik Hofmeyr
Johann RohwerJohann Rohwer
Johann Rohwer
The thioredoxin system consisting of NADP(H), thioredoxin reductase and thioredoxin provides reducing equivalents to a large and diverse array of cellular processes. Despite a great deal of information on the kinetics of individual thioredoxin-dependent reactions, the kinetic regulation of this system as an integrated whole is not known. We address this by using kinetic modeling to identify and describe kinetic behavioral motifs found within the system.

1 February 2018 in BioSystems
Verified
Journal Article
Closed access
JHJan-Hendrik Hofmeyr
Jan-Hendrik Hofmeyr

11 November 2019 in Autophagy
Verified
Journal Article
Closed access
BLBen Loos
Ben Loos
DKDaniel J. Klionsky
Daniel J. Klionsky
ATAndre Du Toit
Andre Du Toit
JHJan-Hendrik Hofmeyr
Jan-Hendrik Hofmeyr
Macroautophagy (which we will call autophagy hereafter) is a critical intracellular bulk degradation system that is active at basal rates in eukaryotic cells. This process is embedded in the homeostasis of nutrient availability and cellular metabolic demands, degrading primarily long-lived proteins and specific organelles.. Autophagy is perturbed in many pathologies, and its manipulation to enhance or inhibit this pathway therapeutically has received considerable attention. Although better probes are being developed for a more precise readout of autophagic activity in vitro and increasingly in vivo, many questions remain. These center in particular around the accurate measurement of autophagic flux and its translation from the in vitro to the in vivo environment as well as its clinical application. In this review, we highlight key aspects that appear to contribute to stumbling blocks on the road toward clinical translation and discuss points of departure for reaching some of the desired goals. We discuss techniques that are well aligned with achieving desirable spatiotemporal resolution to gather data on autophagic flux in a multi-scale fashion, to better apply the existing tools that are based on single-cell analysis and to use them in the living organism. We assess how current techniques may be used for the establishment of autophagic flux standards or reference points and consider strategies for a conceptual approach on titrating autophagy inducers based on their effect on autophagic flux . Finally, we discuss potential solutions for inherent controls for autophagy analysis, so as to better discern systemic and tissue-specific autophagic flux in future clinical applications. Abbreviations: GFP: Green fluorescent protein; J: Flux; MAP1LC3/LC3: Microtubule-associated protein 1 light chain 3; nA: Number of autophagosomes; TEM: Transmission electron microscopy; τ: Transition time